Symptomatic Events in a Community Palliative Care Population : A Prospective Pilot Study
Background: The palliative care population is prescribed a large number of drugs, increasing as patients deteriorate. The cumulative effects of these medications combined with underlying symptom burden can result in significant morbidity. There is an urgent need to describe possible symptomatic events that could be exacerbated by commonly prescribed drugs in palliative care and their impact. Objectives: To trial the feasibility and acceptability of determining baseline symptomatic event rates for community palliative care patients from which a composite measure of symptomatic events can be developed. Design: This prospective pilot study of patient-reported symptomatic events recruited a convenience cohort of 27 community palliative care patients in a metropolitan specialist palliative care service in Australia. Results: This study has demonstrated a high prevalence rate of symptomatic events (total crude event/participant day rate 0.87) in the study population. Conclusion: Data collection of patient-centered symptomatic events was acceptable and feasible to participants. This pilot supports a fully powered study.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
Journal of palliative medicine - 23(2020), 9 vom: 19. Sept., Seite 1223-1226 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
To, Timothy H M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adverse events |
|---|
| Anmerkungen: |
Date Completed 18.06.2021 Date Revised 18.06.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1089/jpm.2019.0407 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM305131125 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM305131125 | ||
| 003 | DE-627 | ||
| 005 | 20231225120516.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1089/jpm.2019.0407 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1017.xml |
| 035 | |a (DE-627)NLM305131125 | ||
| 035 | |a (NLM)31913763 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a To, Timothy H M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Symptomatic Events in a Community Palliative Care Population |b A Prospective Pilot Study |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.06.2021 | ||
| 500 | |a Date Revised 18.06.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Background: The palliative care population is prescribed a large number of drugs, increasing as patients deteriorate. The cumulative effects of these medications combined with underlying symptom burden can result in significant morbidity. There is an urgent need to describe possible symptomatic events that could be exacerbated by commonly prescribed drugs in palliative care and their impact. Objectives: To trial the feasibility and acceptability of determining baseline symptomatic event rates for community palliative care patients from which a composite measure of symptomatic events can be developed. Design: This prospective pilot study of patient-reported symptomatic events recruited a convenience cohort of 27 community palliative care patients in a metropolitan specialist palliative care service in Australia. Results: This study has demonstrated a high prevalence rate of symptomatic events (total crude event/participant day rate 0.87) in the study population. Conclusion: Data collection of patient-centered symptomatic events was acceptable and feasible to participants. This pilot supports a fully powered study | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a adverse events | |
| 650 | 4 | |a anticholinergic load | |
| 650 | 4 | |a palliative care | |
| 650 | 4 | |a patient safety | |
| 650 | 4 | |a prescribing | |
| 700 | 1 | |a Collier, Aileen |e verfasserin |4 aut | |
| 700 | 1 | |a Agar, Meera R |e verfasserin |4 aut | |
| 700 | 1 | |a Rowett, Debra |e verfasserin |4 aut | |
| 700 | 1 | |a Currow, David C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of palliative medicine |d 1998 |g 23(2020), 9 vom: 19. Sept., Seite 1223-1226 |w (DE-627)NLM097464821 |x 1557-7740 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2020 |g number:9 |g day:19 |g month:09 |g pages:1223-1226 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1089/jpm.2019.0407 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2020 |e 9 |b 19 |c 09 |h 1223-1226 | ||